In Brief: Cephalon Myotrophin
Executive Summary
Cephalon Myotrophin: Treatment IND registration begins for amyotrophic lateral sclerosis drug through the National Organization for Rare Disorders. Several hundred patients will be selected from the registration pool to receive Myotrophin under a lottery system since Cephalon does not yet have sufficient supplies to provide the drug on an unlimited basis. Parexel is managing the treatment protocol ("The Pink Sheet" June 24, T&G-2). Cephalon has not yet filed for approval of Myotrophin...